Mattan Lurie

Investor focused on alternative protein, food‑tech and healthcare — pragmatic, technology‑first approach. Lurie frequently advises and presents on the alt‑protein sector (plant‑based, precision fermentation, cultivated meat), arguing investors should prioritise technological defensibility and supply‑chain or scaleable production advantages over purely brand/marketing plays. researchgate+1

Family‑office and cross‑border investor active in APAC and Greater China. He represents and speaks for family‑office platforms (VenturesLab) and participates in regional family‑office/PE forums, reflecting experience allocating Asia‑based LP capital into healthcare and technology opportunities while navigating geopolitical and regulatory sensitivities. privateequityinternational+1

Seasoned PE/VC practitioner with a mixed background across investment banking, private equity, corporate development and family‑office investing. His career path (CLSA → Hony → Fosun → Ally Bridge → Hanaco/Brinc → VenturesLab) shows deep China/Asia transaction experience and a transition toward advising and allocating capital into early‑stage food‑tech and medtech. about+1